Oral bisphosphonates associated with Clostridium difficile infection

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-016-22018-1
中图分类号
学科分类号
摘要
引用
收藏
页码:11 / 11
相关论文
共 50 条
  • [31] Clostridium difficile infection
    Kelly, CP
    LaMont, JT
    ANNUAL REVIEW OF MEDICINE, 1998, 49 : 375 - 390
  • [32] Clostridium difficile Infection
    Germansky, Katharine A.
    Kelly, Ciaran P.
    HOSPITAL MEDICINE CLINICS, 2012, 1 (01) : E69 - E86
  • [33] Clostridium difficile infection
    不详
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2014, 145 (07): : 784 - 784
  • [34] Clostridium difficile infection
    Alcala Hernandez, Luis
    Reigadas Ramirez, Elena
    Bouza Santiago, Emilio
    MEDICINA CLINICA, 2017, 148 (10): : 456 - 463
  • [35] Clostridium difficile Infection
    Downes, Kevin J.
    Shah, Samir S.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2013, 2 (01) : 83 - 86
  • [36] Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin
    Bunnell, Kristen L.
    Danziger, Larry H.
    Johnson, Stuart
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (02):
  • [37] Impact of Delayed Oral Vancomycin for Severe Clostridium difficile Infection
    Shah, Sunish
    Ereshefsky, Benjamin
    Pontiggia, Laura
    Cawley, Michael
    HOSPITAL PHARMACY, 2019, 54 (05) : 294 - 299
  • [38] Clostridium difficile infection
    Wiep Klaas Smits
    Dena Lyras
    D. Borden Lacy
    Mark H. Wilcox
    Ed J. Kuijper
    Nature Reviews Disease Primers, 2
  • [39] Clostridium difficile infection
    Biedermann L.
    Rogler G.
    Der Gastroenterologe, 2017, 12 (3): : 237 - 252
  • [40] Clostridium difficile Infection
    Facciorusso, Antonio
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (03): : 286 - 287